Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
Identifying maternal DNA methylation based biomarkers of spina bifida risk in a Bangladesh case-control study
EF 2025-26
Résumé
Spina bifida is a condition where the spinal cord fails to close in development, causing nerve damage, paralysis, and bladder or bowel problems. Taking folic acid in pregnancy reduces risk, but exposure to arsenic can offset this benefit. In Bangladesh, spina bifida rates are high due to widespread arsenic contamination in well water. To prevent future cases, we must better understand how genetics, folic acid, and arsenic together influence risk.
Our project studies birthing parents of children with or without spina bifida from Bangladesh. We use genetic data from 374 parents (246 with affected children) plus measured arsenic and folic acid levels to look at chemical marks in DNA called "DNA methylation". These marks show how genes are working, and reveal the impact of life exposures.
First, we use these marks to measure "epigenetic age", which is often higher in people with poor health or more harmful exposures. We think parents of affected children with more risk factors (low folic acid or high arsenic) will have higher epigenetic ages than parents of unaffected children. We will confirm these findings in another group of 105 families (48 with spina bifida).
Second, we will find genetic marks that can be measured in parental blood where differences in the genetic code, like typos, can change DNA methylation marks and are also linked to spina bifida. These regions, called "mQTLs", show how genetics and the environment work together to increase risk of spina bifida. We will check which regions are related to both spina bifida and arsenic or folic acid, and confirm the findings in the second group of families.
Our work will identify genetic markers in parents linked to risk of spina bifida in their children. These results will better identify individuals at high risk of having children with spina bifida before they are pregnant, and may point us in the direction of future treatment strategies.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
536769
Name
Inkster Amy
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Identifying maternal DNA methylation based biomarkers of spina bifida risk in a Bangladesh case-control study
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Arsenic; Dna Methylation; Epigenetic Age; Epigenetics; Folate; Maternal; Mother-Child Health; Neural Tube Defects; Spina Bifida; Women'S Health
Abstract
Spina bifida is a condition where the spinal cord fails to close in development, causing nerve damage, paralysis, and bladder or bowel problems. Taking folic acid in pregnancy reduces risk, but exposure to arsenic can offset this benefit. In Bangladesh, spina bifida rates are high due to widespread arsenic contamination in well water. To prevent future cases, we must better understand how genetics, folic acid, and arsenic together influence risk.
Our project studies birthing parents of children with or without spina bifida from Bangladesh. We use genetic data from 374 parents (246 with affected children) plus measured arsenic and folic acid levels to look at chemical marks in DNA called "DNA methylation". These marks show how genes are working, and reveal the impact of life exposures.
First, we use these marks to measure "epigenetic age", which is often higher in people with poor health or more harmful exposures. We think parents of affected children with more risk factors (low folic acid or high arsenic) will have higher epigenetic ages than parents of unaffected children. We will confirm these findings in another group of 105 families (48 with spina bifida).
Second, we will find genetic marks that can be measured in parental blood where differences in the genetic code, like typos, can change DNA methylation marks and are also linked to spina bifida. These regions, called "mQTLs", show how genetics and the environment work together to increase risk of spina bifida. We will check which regions are related to both spina bifida and arsenic or folic acid, and confirm the findings in the second group of families.
Our work will identify genetic markers in parents linked to risk of spina bifida in their children. These results will better identify individuals at high risk of having children with spina bifida before they are pregnant, and may point us in the direction of future treatment strategies.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Inkster, Amy
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~